Embecta Corp. (EMBC) stock
EMBCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 15/3079% below fair value
$6.43−0.10 (-1.53%)
Close on Nov 12, 2026Market cap $364.32MP/E 4.4Yield 9.33%
Embecta enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Embecta's enterprise value was $1.61B on Nov 11, 2026, against $1.92B a year earlier. Over the last 5 years it ranged from $1.33B to $3.16B, with a median of $2.13B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.61B | -13.8% |
| 2025 | Dec 31, 2025 | $1.87B | -25.1% |
| 2024 | Dec 31, 2024 | $2.49B | +5.5% |
| 2023 | Dec 29, 2023 | $2.36B | -13.1% |
| 2022 | Dec 30, 2022 | $2.72B | – |
See a number that looks wrong?